Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express
PETSMIAMI--(BUSINESS WIRE)--Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-binding proposal to acquire PetMed Express, Inc. (Nasdaq: PETS) (“PetMeds”) for $4.25 per share in cash, representing an implied equity value of approximately $89 million. The proposal was delivered to the Board of Directors of PetMed Express and is not subject to any financing contingency, reflect
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
PETSDELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds’ giftable assortment focuses on products that improve pets’ everyday health, comfort, safety, and happiness, making them ideal for the pet owner who has everything.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
PETSNEW YORK, Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
PetMed Express, Inc. Announces Management Changes
PETSDELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D’Elia, have resigned from their positions and employment with the Company.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
PETSNEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
PetMed Express Delays Q4 And FY25 Earnings; To Issue Earnings Release, Hold Call And File Annual Report On 10-K No Later Than June 16, 2025
PETSWhat to Expect from PetMed Express's Earnings
PETSSilvercape Investments Says Intends To Engage In Discussions With PetMed Express' Management And/Or Co's Board; It May Also Discuss Possibility Of Nominating Person To Become Director Of PetMed Express
PETSPetMed Express 13G Filing Shows SilverCape Investments Reported A 11.1% Stake In The Co As Of May 18, 2025
PETSPetMed Express Partners With Dutch To Provide Accessible Telehealth Services For Pets
PETSMorgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2
PETSPetMed Express Q2 2025 GAAP EPS $0.11 Beats $(0.05) Estimate, Sales $59.570M Miss $66.000M Estimate
PETS